Dynavax Technologies Corp reports results for the quarter ended December 31 - Earnings Summary

• Dynavax Technologies Corp DVAX.OQ reported quarterly adjusted earnings of 5 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported breakeven earnings per share. The mean expectation of five analysts for the quarter was for earnings of 4 cents per share. Wall Street expected results to range from 2 cents to 6 cents per share.

• Revenue rose 27.8% to $71.05 million from a year ago; analysts expected $72.70 million.

• Dynavax Technologies Corp's reported EPS for the quarter was 5 cents​.

• The company reported quarterly net income of $7.05 million.

• Dynavax Technologies Corp shares had risen by 2.5% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 10.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Dynavax Technologies Corp is $25.00

This summary was machine generated from LSEG data February 20 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)